With some similarity to the discovery of nodal/paranodal antibodies in chronic neuropathies, MS has recently been separated from other distinct, serologically-defined disorders, characterised by the presence of aquaporin-4 or myelin oligodendrocyte glycoprotein (MOG) directed autoantibodies. Here, AQP4 is linked to myeloid sarcoma.